Avenue Therapeutics, Inc. (ATXI): Price and Financial Metrics
ATXI Price/Volume Stats
| Current price | $1.77 | 52-week high | $26.47 |
| Prev. close | $1.80 | 52-week low | $1.60 |
| Day low | $1.76 | Volume | 29,600 |
| Day high | $1.91 | Avg. volume | 57,252 |
| 50-day MA | $2.03 | Dividend yield | N/A |
| 200-day MA | $4.24 | Market Cap | 3.64M |
ATXI Stock Price Chart Interactive Chart >
Avenue Therapeutics, Inc. (ATXI) Company Bio
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes an intravenous formulation of tramadol HCI principally for use in the acute/intensive care hospital setting. Its product candidate is IV Tramadol for the treatment of post-operative pain. The company was founded in 2015 and is based in New York, New York.
ATXI Price Returns
| 1-mo | -11.94% |
| 3-mo | -28.05% |
| 6-mo | -51.90% |
| 1-year | -83.66% |
| 3-year | -99.83% |
| 5-year | -99.98% |
| YTD | -85.34% |
| 2023 | -86.12% |
| 2022 | -91.48% |
| 2021 | -84.74% |
| 2020 | -38.02% |
| 2019 | 77.78% |
Loading social stream, please wait...